WASHINGTON, July 29- The U.S. Defense Department on Wednesday awarded a team led by Leidos Holdings Inc a contract valued at up to $4.34 billion to build a new electronic health record system for 9.6 million current and retired military service members. The Pentagon's chief arms buyer, Frank Kendall, said the contract was worth under $9 billion over the next 18...» Read More
In what could be the ultimate in personalized medicine, animals bearing your disease, or part of your anatomy, can serve as your personal guinea pig, so to speak. Some researchers call them avatars, like the virtual characters in movies and online games the New York Times reports.
Despite gloomy data out of China weighing on the outlook for U.S. earnings, U.S. equities are looking attractive for U.S. investors, Sam Peters, CIO and portfolio manager at global investment management firm Leg Mason Capital Management, told CNBC on Thursday.
What the latest employment figures mean, experts say, is that getting the U.S. back to work remains—and is expected to be—a slow and painful process.
Alarm bells over the lack of high tech workers in the U.S. have been ringing for years. Most analysts say the problem is worse, but some say it's overblown.
Faced with more service members returning without limbs from Iraq and Afghanistan, scientists, the government and private-sector companies are using new materials, tools and techniques to create sophisticated prostheses for amputees.
If you're worried about how yours might fare during a downturn, consider a recession-proof industry, which caters to ongoing demands.
The “Mad Money” host admits he made a mistake, and now recommends a different name in the health care information technology wars.
Medical device maker, Abiomed's CEO, Michael Minogue, discusses his company's earnings beat, and whether the ultra expensive stock, selling for 5.8 times next year's sales, still has room to run, with Mad Money's Jim Cramer.
Physicians are embracing Web-based software solutions that are bringing healthcare services into the home.
A spokesman for the medical-technology industry warned that a new medical-device tax that goes into effect in 2013 under the Obama health-care law could force some companies to cut jobs.
Here is our list of the 15 of the most influential inventions over the past 50 years, created using a variety of studies as reference points, including ones from Knowledge@Wharton and Popular Mechanics.
Though the U.S. had made much progress taking medical record keeping into the digital age, there's still some doubt that the government will reach its target by the prescribed deadline.
The federal government has received a surge in complaints in recent months about failed hip replacements, suggesting that serious problems persist with some types of artificial hips even as researchers scramble to evaluate the health dangers. The New York Times reports.
Blood-testing equipment maker Immucor says it agreed to be acquired by TPG Capital in a deal worth $1.97 billion, or $27 per share in cash.
Ranking No. 1 for the 5th year running, California surpassed even its own 2010 performance. Yet, tech-savvy runners-up to the Silicon Valley state aren’t that far behind.
Making a case for lap-band surgery and discussing the benefits to patients and insurance companies, with David Pyott, Allergan CEO.
A new test developed by a unit of biotech company Life Technologies has shown success in quickly pinpointing the strain of E. coli involved in a European outbreak that has killed 25 people and sickened more than 2,400 worldwide.
While growing computing demand will mean more energy consumption, wider use of cloud computing technology will prove to be a net benefit to the environment over the longer term, say industry watchers.
Rep. Ron Paul (R-TX) outlines his bid for US president. "Why have we given up on the free market?" he says. "What we're doing is destroying the purchasing power of the dollar."
Medtronic, the world's largest medical device maker, says its fourth-quarter net income dropped 19 percent on expenses related to its recent layoffs.